Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study

Osteoporosis International

Volumn 7, Issue 2, 1997, Pages 126-132

  Komulainen, M ^a,b   Tuppurainen, M T ^a,b   Kroger H ^a,b   Heikkinen, A M ^a,b   Puntila, E ^b   Alhava, E ^a,b   Honkanen, R ^b,c   Saarikoski, S ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Bone mineral density; Cyproterone acetate; Hormone replacement therapy; Osteoporosis; Postmenopause; Vitamin D

Indexed keywords

COLECALCIFEROL; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; D CALSOR; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030895564     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01623687     Document Type: Article

References (20)

1. Hirvonen E, Elliesen J, Schmidt-Gollwitzer K. Comparison of two hormone replacement regimens: influence on lipoproteins and bone mineral content. Maturitas 1990;12:127-36.
2. Lips P, Wiersinga A, van Ginkel FC, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644-50.
3. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505-12.
4. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
5. Kroger H, Heikkinen J, Laitinen K, Kotaniemi A. Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers. Osteoporosis Int 1992;2:135-40.
6. Christensen MS, Hagen C, Christiansen D, Transbol IB. Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions. Am J Obstet Gynecol 1982;144:873-9.
7. 3. Maturitas 1995;22:55-61.
8. Marslew U, Overgaard K, Riis BJ, Christiansen C. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol 1992;79:202-10.
9. Kleemola P, Virtanen M, Pietinen P. The 1992 dietary survey of Finnish adults. Publication of the National Public Health Institute, Helsinki B2/1994.
10. National Research Council. Recommended dietary allowances: subcommittee on the tenth edition of the RDAs. Food and Nutrition Board, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press, 1989.
11. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995;98:331-5.
12. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878-83.
13. Riis BJ, Jensen J, Christiansen C. Cyproterone acetate, an alternative gestagen in postmenopausal estrogen/gestagen therapy? Clin Endocrinol 1987;26:327-34.
14. Pouilles JM, Tremollieres F, Ribot C. Effect of menopause on femoral and vertebral bone loss. J Bone Miner Res 1995;10:1531-6.
15. Holland EFN, Leather AT, Studd JWW, Garnett TJ. The effect of a new sequential oestradiol valerate and levonorgestrel preparation on the bone mineral density of postmenopausal women. Br J Obstet Gynaecol 1993;100:966-7.
16. Dören M, Reuther G, Minne HW, Schneider HPG. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol 1995;173:1446-51.
17. Kröger H, Huopio J, Honkanen R, et al. Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res 1995;10:302-6.
18. Lips P, Gramans WC, Ooms ME, Bezemer PD, Bouter LM. The effect of vitamin D supplementation on the incidence of hip fractures in elderly people [abstract]. J Bone Miner Res 1994;9(Suppl 1):S148.
19. Ooms ME, Roos JE, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80:1052-8.
20. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995;61:1140-5.